Building biotech in Southern California

Monday, February 24, 2003

If you are an EDPro involved in biotech investments, you'll want to read this review of developments in Southern California.

The article underlines an important point. Business development in biotech is inherently complex and collaborative. You don't see a Bill Gates or a Henry Ford in biotech for a reason. Regions have to have both a strong research base and specialized professional networks to translate this research into business.

Although many regions are pushing biotech development, only a few will likely create major job generators. For a review, see a recent Brookings Institution report.

I speak from hard experience. Eighteen years ago, I started the Biomedical Research Foundation of Northwest Louisiana. Although we have boosted the research base from $1.5 million a year to over $10 million a year, biotech business development has only recently started to take root. (The corruption of Louisiana politics has also slowed the process considerably.)

More recently, I worked in Oklahoma City to boost biotech investment there. While the research base much larger here, accelerating business development is also slow.

Now, I'm working in Charleston with the Medical University South Carolina. The prospects here seem good. MUSC has a strong, expanding research base that produces good science. The state is accelerating it's commitments to biotech. The one wild card: the business development networks in Charleston are relatively weak.

For those of you involved in biotech, the National Science Foundation has a good resource for EDPros in Bio-Link, a web site that explores how to prepare a biotech workforce.

posted by Ed Morrison |

Subscribe with Bloglines






Creative Commons License
This work is licensed under a Creative Commons License.
links
Google
The Web EDPro Weblog